Bioinformatics imaginaries in the engine-room of genomic health policy

integration and heterogeneity in India and the UK

  • Alex Faulkner University of Sussex


Bioinformatics comprises a diffuse field of technologies, knowledges, databases and software for medical and pharmaceutical innovation. It is becoming a major target of policymaking for global health goals, but experiences conflicts including over ownership and access; national versus commercial agendas; disease targeting; genomic versus clinical data. The paper draws on the political economy of states, and the performativity of policy and ‘sociotechnical imaginaries’ to identify diverging framings and imaginaries in a comparison of India and the UK. It argues that bioinformatics policies are diversified in India and increasingly co-ordinated in the UK; integration of clinical with genomic data is more prominent in the UK and more geared to hegemonic ‘platform’ technologies; India has more nation-focused, societal policy in disease strategies, and notable heterogeneity in the social production of genomic knowledge. The paper develops STS concepts by linking them to political state theory, highlighting social heterogeneity in technoscientific innovation.


Download data is not yet available.


Afshinnekoo E, Ahsanuddin S, Mason CE (2016) Globalizing and crowdsourcing biomedical research. British Medical Bulletin 120 (1): 27-33. doi:
Årdal C, Røttingen J-A (2012) Open Source Drug Discovery in Practice: A Case Study. PLoS Neglected Tropical Diseases 6(9): e1827. doi:10.1371/journal.pntd.0001827
Banerjee M (2011) Is pharmacogenomics a reality? Challenges and oppurtunities for India. Indian J Human Genetics, 17(Suppl 1): S1–S3. doi: 10.4103/0971-6866.80350
Baren-Nawrocka J v. (2013) The bioinformatics of genetic origins: how identities become embedded in the tools and practices of bioinformatics. Life Sciences, Society and Policy 9: 7.
Benjamin R (2009) A lab of their own: genomic sovereignty as postcolonial science policy. Policy and Society 28: 341-355.
Beuma K, Bhattacharya S (2013) Emerging technologies in India: Developments, debates and silences about nanotechnology. Science & Public Policy 40(5): 628-643.
Brahmach, OSDD Director. (undated) speech/presentation video. Available at: (accessed 7.7.2016)
Chang J, Zhu X (2010) Bioinformatics databases: intellectual property protection strategy. Journal of Intellectual Property Rights 15: 447-454.
DBT (Department of Biotechnology, India) (2011). Bioinformatics. Report. New Delhi.
Daar AS, Thorsteinsdottir H, Martin DK, Smith AC, Nast S, Singer PA (2002) Top ten biotechnologies for improving health in developing countries. Nature Genetics 32(2):229-232.
Etzkowitz H. (2008) The Triple Helix: University-Industry-Government Innovation in Action. London: Routledge.
European Society for Translational Medicine (2014) Translational Medicine definition by the European Society for Translational Medicine. New Horizons in Translational Medicine 2(3): 86–88. doi:10.1016/j.nhtm.2014.12.002
Faulkner A (2009) Regulatory policy as innovation: constructing rules of engagement of a technological zone for tissue engineering in the European Union. Research Policy 38(4): 637-646.
Faulkner A (2012) Law’s performativities: shaping the emergence of regenerative medicine through European Union legislation. Social Studies of Science 42: 753-774.
Fears R, Poste G (1999) Building population genetics resources using the UK NHS. Science 284(5412): 267-268.
Felt U (2014) Sociotechnical imaginaries of “the internet”, digital health information and the making of citizen-patients. In: Hilgartner S, Miller C, Hagendijk R (eds) Science and Democracy: Making Knowledge and Making Power in the Biosciences and Beyond. London/New York: Routledge. Preprint available at (Accessed 10.10.2016).
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D. and Bray F. (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136: E359–E386. doi:10.1002/ijc.29210
Gates W (2009) Bill Gates Keynote – Carnegie-Mellon University. Available at: (accessed 10.10.2016).
Genomics England (2016) Research in the 100,000 Genomes Project. Available at: about-gecip/ (accessed 10.10.2016).
Gee JP (2014) An Introduction to Discourse Analysis: theory and method. 4th edition, Abingdon: Routledge.
GeneWatch UK (2015) Data Protection or exploitation? The erosion of safeguards for health and genetic research. Available at: (accessed 21.1.2016).
Goodall S, Janssens B, Wagner K, Wong J, Woods W, Yeh M (2006) The promise of the East: India and China as R & D options. Nature Biotecnology 24(9): 1064.
Hardy B-J, Séguin B, Goodsaid F, Jimenez-Sanchez G, Singer PA, Daar AS.(2008) Nature Reviews Genetics – Genomic medicine in developing countries. October 2008 s23. doi:10.1038/nrg2379
Harvey M, McMeekin A (2002) UK Bioinformatics: Current Landscapes and Future Horizons. London: Department of Trade and Industry.
Harvey M, McMeekin A (2005) Brazilian genomics and bioinformatics: instituting new innovation pathways in a global context, Economy and Society 34(4): 634-658, DOI: 10.1080/03085140500277260
Harvey M, McMeekin A (2009) Public or private economies of knowledge: The economics of diffusion and appropriation of bioinformatics tools. International Journal of the Commons, North America 4(1):.481–506.
Hay C (2004) Re-stating politics, re-politicising the state: neo-liberalism, economic imperatives and the rise of the competition state. Political Quarterly 75(1): 38-50.
Hirsch J (1991) From the Fordist to the post-Fordist state. In: Jessop B (ed) The politics of flexibility: restructuring state and industry in Britain, Germany and Scandinavia. Aldershot: Edward Elgar.
Howard K (2000) The bioinformatics gold rush. Scientific American 283(1): 58-63.
Jasanoff S (2004) States of knowledge: co-production of science and social order. Routledge, London.
Jasanoff S (2015) Future Imperfect: Science, Technology and the Imaginations of Modernity. In: Jasanoff S, Kim S-H (eds) Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power. Chicago: University of Chicago Press, pp1-33.
Jasanoff S , Kim S-H (2009) Containing the Atom: Sociotechnical Imaginaries and Nuclear Power in the United States and South Korea. Minerva 47(2): 119-146.
Jasanoff S, Kim S-H (2013) Sociotechnical Imaginaries and National Energy Policies. Science as Culture 22(2):189-196.
Jasanoff S, Kim S-H (2015) (eds) Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power. University of Chicago Press.
Kale D, Little S (2007) From imitation to innovation: the evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry. Technology Analysis and Strategic Managemen, 19 (5): 589–609.
Kerr A (2003) Governing genetics: Reifying choice and progress. New Genetics & Society 22(2): 143-158.
Kim YT (1999) Neoliberalism and the decline of the developmental state. Journal of Contemporary Asia 29(4): 441-62.
Lee K, Kamradt-Scott A (2014) The multiple meanings of global health governance: a call for conceptual clarity. Globalization and Health 14: 10-28. doi: 10.1186/1744-8603-10-28

Leonelli S (2014). What Difference Does Quantity Make? On the Epistemology of Big Data in Biology. Big Data and Society 1 (1): 1-11.
Lewis J, Bartlett A (2013) Inscribing a discipline: tensions in the field of Bioinformatics. New Genetics and Society 32(3): 243–263.
Mackenzie A (2003) Bringing sequences to life: how bioinformatics corporealizes sequence data. New Genetics and Society 22 (3): 315-332.
Martin P, Hollin G. (2014) A new model of innovation in biomedicine? Nuffield Council on Bioethics. Available at: (accessed 15.11.2015).
McNally R, Glasner P (2006) Transcending the genome? Studying life in the proteomic bioscape, in Glasner P & Atkinson P (eds) New Genetics, New Social Formations. London: Routledge.
Meekings KN, Williams CSM, Arrowsmith JE (2012) Orphan drug development: an economically viable strategy for biopharma R&D. Drug Discovery Today 17(13/14): 660-664.
Nuffield Council on Bioethics (2015) The collection, linking and use of data in biomedical research and health care: ethical issues. Available at: (accessed 15.1.2016).
Parker M (2013) (Letter to Government’s Chief Medical Officer about Genomics England Ethics Working Group)) Available at: (accessed 15.11.2015).
Parveen J (2010) India step closer to personalized medicine. Biospectrum 7 October 2010. Available at: (accessed 15.11.2015)
Peplow M (2016) The 100,000 Genomes Project. British Medical Journal,353:i1757-9.
Public Health England (2016). Tuberculosis in England, 2016 Report. Available at: (accessed 10.10.2016).
RNCOS (2012) Indian Bioinformatics Market Forecast to 2015. RNCOS:Noida, India.
Rhodes RAW (1996) The new governance: governing without government. Political Studies 44(4): 652-667
Salter B, Faulkner A (2011) State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding ‘Rising Powers’ in the global context. Globalization and Health 7:3.
Salter B, Faulkner A, Hogarth S (2012) Research summary ‘State strategies of governance in global biomedical innovation: the impact of China and India’. Available at:
Salter B, Zhou Y, Datta S, Salter C (2015) Bioinformatics and the Politics of Innovation in the Life Sciences: Science and the State in the United Kingdom, China, and India. Science, Technology and Human Values 41(5) 793-826.
Sariola S, Ravindran D, Kumar A, Jeffery R. (2015) Big-pharmaceuticalisation: Clinical trials and Contract Research Organisations in India. Social Science & Medicine 131: 239-246.
Secretary of State for Health (2009) Government Response to the House of Lords Science and Technology Committee Inquiry into Genomic Medicine. The Stationery Office: London.
Shirodkar SN (2010) National Institute of Biomedical Genomics to become operational from April 2010. Available at: (accessed 30.1.2017).
Sleeboom-Faulkner M, Chekar CK, Faulkner A, Heitmeyer C, Marouda M, Rosemann, A, Chaisinthop N, Chang H-C, Ely A, Kato M, Patra PK, Su Y, Sui S, Suzuki W, Zhang X (2016) Comparing national home-keeping and the regulation of translational stem cell applications: an international perspective. Social Science and Medicine 153: 240-249.
Stevens H (2013) Life Out of Sequence: A data-driven history of bioinformatics. Chicago: University of Chicago Press.
Suarez-Diaz E (2010) Making Room for New Faces: Evolution, Genomics and the Growth of Bioinformatics. History and Philosophy of the Life Sciences 32: 65–90.
Sunder Rajan K. (2006) Biocapital: The Constitution of Postgenomic Life. Durham, North Carolina: Duke University Press.
Sunder Rajan K, Leonelli S (2013) Introduction: Biomedical Trans-Actions, Postgenomics and Knowledge/Value. Public Culture: society for transnational cultural studies 25(3): 463-475.
Taylor L (2013) UK life sciences let down by poor informatics skills, experts warn. Pharma Times, March 26. Available at: (accessed 15.11.2015)
WHO website. ‎ (accessed 14.10.2013).
Weiss L (2000) Developmental states in transition: adapting, dismantling, innovating, not ‘normalising’. The Pacific Review 13(1): 21-55, 29.
Wu Y (2004) Rethinking the Taiwanese developmental state. The China Quarterly 177: 91-114.
Zwart H (2009) Genomics and identity: the bioinformatisation of human life. Medicine Health Care and Philosophy 12(2): 125–136.
Special Issue: STS And Global Health